First-in-Human Clinical Trial of a Small Molecule EBNA1 Inhibitor, VK-2019, in Patients with Epstein-Barr Positive Nasopharyngeal Cancer, with Pharmacokinetic and Pharmacodynamic Studies.
Clinical cancer research an official journal of the American Association for Cancer Research（2025）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined